GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,252,000 | -84.9% | 143,615 | -84.9% | 0.00% | -76.9% |
| Q1 2022 | $41,371,000 | +52.9% | 949,748 | +54.8% | 0.01% | +44.4% |
| Q4 2021 | $27,053,000 | +6.9% | 613,455 | -7.4% | 0.01% | 0.0% |
| Q3 2021 | $25,318,000 | +1.1% | 662,600 | +5.3% | 0.01% | 0.0% |
| Q2 2021 | $25,053,000 | +67.9% | 629,154 | +50.5% | 0.01% | +12.5% |
| Q1 2021 | $14,917,000 | -47.7% | 417,935 | -46.1% | 0.01% | -42.9% |
| Q4 2020 | $28,514,000 | -52.1% | 774,809 | -51.0% | 0.01% | -60.0% |
| Q3 2020 | $59,547,000 | +266.0% | 1,582,032 | +296.7% | 0.04% | +218.2% |
| Q2 2020 | $16,269,000 | +194.9% | 398,845 | +173.9% | 0.01% | +120.0% |
| Q1 2020 | $5,516,000 | -93.6% | 145,597 | -92.1% | 0.01% | -95.8% |
| Q4 2019 | $86,098,000 | -20.3% | 1,832,237 | -27.6% | 0.12% | -32.6% |
| Q3 2019 | $108,077,000 | +48.7% | 2,532,246 | +39.4% | 0.18% | +38.0% |
| Q2 2019 | $72,693,000 | +4053.9% | 1,816,424 | +4238.2% | 0.13% | +4200.0% |
| Q1 2019 | $1,750,000 | -96.2% | 41,870 | -96.5% | 0.00% | -96.9% |
| Q4 2018 | $45,989,000 | -17.4% | 1,203,590 | -13.2% | 0.10% | -11.8% |
| Q3 2018 | $55,671,000 | -14.5% | 1,385,873 | -14.2% | 0.11% | -28.1% |
| Q2 2018 | $65,132,000 | +763.9% | 1,615,765 | +737.3% | 0.15% | +665.0% |
| Q1 2018 | $7,539,000 | +31.3% | 192,969 | +19.2% | 0.02% | +17.6% |
| Q4 2017 | $5,740,000 | +2291.7% | 161,827 | +2642.8% | 0.02% | +1600.0% |
| Q3 2017 | $240,000 | -99.3% | 5,900 | -99.2% | 0.00% | -99.1% |
| Q2 2017 | $33,288,000 | +2376.8% | 771,974 | +2112.0% | 0.12% | +2240.0% |
| Q4 2016 | $1,344,000 | -21.9% | 34,900 | -12.5% | 0.01% | -37.5% |
| Q3 2016 | $1,720,000 | -51.0% | 39,867 | -50.8% | 0.01% | -52.9% |
| Q2 2016 | $3,513,000 | -95.2% | 81,067 | -95.5% | 0.02% | -95.8% |
| Q1 2016 | $72,831,000 | -16.4% | 1,796,056 | -16.8% | 0.41% | -24.5% |
| Q4 2015 | $87,116,000 | +137.7% | 2,159,016 | +126.5% | 0.54% | +135.7% |
| Q3 2015 | $36,655,000 | +4.1% | 953,332 | +12.8% | 0.23% | +1.3% |
| Q2 2015 | $35,202,000 | +4618.8% | 845,170 | +5132.3% | 0.23% | +3683.3% |
| Q1 2015 | $746,000 | -99.0% | 16,153 | -99.1% | 0.01% | -99.0% |
| Q4 2014 | $77,785,000 | – | 1,819,956 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |